Transplant Diagnostics Market

The global transplant diagnostics market size was estimated at USD 3.95 billion in 2021 and is anticipated to expand at a CAGR of 7.2% between 2023 to 2032.

The global market is anticipated to witness significant growth in coming years. Some of the major factors driving the market growth include rising number of cases for organ transplants and extensive research and development activities across the globe. There is a gap between demand supply of organs as the demand is always higher than the supply. In order to bridge the gap, the European Commission has taken an initiative for organ harvesting which resulted in accessibility of donated organs.

Availability of European donor card and rising awareness regarding transplant diagnostics is anticipated to fuel the market growth during the forecast period. Moreover, rising awareness regarding organ donations among U.S. population and increasing number of patients suffering from chronic diseases is expected to positively influence the market growth. Organ failure is very common among patients suffering from chronic diseases.

Furthermore, adoption of personalized medicines and stem cell therapy is increasing rapidly. This in turn, leading to rise the demand for pre-diagnostics significantly. However, stringent regulations such as Organ Transplantation Act which implemented for organ donors to restrict reimbursement policies might hamper the growth of the global market.

By region, North America is anticipated to be the dominant region throughout the forecast period. The region occupied highest market share in 2019. The growth of North America region can be attributed to high adoption of advanced diagnostic tools and techniques, availability of skilled professionals, and continuous investment in healthcare sector.  In addition, increasing adoption of soft tissue transplants, stem cell therapies, and personalized medicines is expected to create growth opportunities for transplant diagnostics market in North America. The U.S. is anticipated to be the highest contributor in the regional growth by holding larger market share as compared with other countries. This is mainly due to highly developed healthcare infrastructure in the U.S.

Transplant Diagnostics Market Value Share Analysis, by Geography (2022)

The report titled “Transplant Diagnostics Market- Global Market Share, Trends, Analysis and Forecasts, 2023-2032”wherein 2021 is historic period, 2022 is the base year, and 2023 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global Transplant Diagnostics Market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.

The global Transplant Diagnostics Market is segmented on the basis of technology, product & service, transplant type, application, end-user, and geography. Based on technology, the global market can be segmented into molecular assay technologies and assay technologies. The molecular assay technologies can further sub segmented into sequencing based molecular assays and PCR-based molecular assays. By product & service, the global market can be segmented into software & services, instruments, and reagents & consumables. Based on transplant type, the global market can be divided into Bone marrow Transplantation, Solid Organ Transplantation, Soft Tissue Transplantation, and Stem Cell Transplantation. Furthermore, on the basis of application, the global market can be segregated into diagnostic applications and research applications. The diagnostic application segment can be sub-segmented into pre-transplantation diagnostics and post-transplantation diagnostics. The end-user segment can be segmented into Research Laboratories & Academic Institutes, Hospitals & Transplant Centers, and Independent Reference Laboratories. Based on geography, the global Transplant Diagnostics Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America is sub-segmented into the United States, Canada and Rest of North America. Europe is sub-segmented into Germany, United Kingdom, Belgium, Spain, and Rest of Europe. Asia Pacific is sub-segmented into China, Japan, India, Australia, and Rest of Asia Pacific. Middle East & Africa is sub-segmented into Saudi Arabia, the UAE, and Rest of Middle East & Africa. South America is sub-segmented into Brazil and Rest of South America.

The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment and would identify the segment of the company focusing on Transplant Diagnostics. Further, market share of prominent companies in the global Transplant Diagnostics Market would also be estimated.

The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, swot analysis, and research and development focus of all the Transplant Diagnostics device companies. The global Transplant Diagnostics Market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution. Product portfolio would focus on all the products under the Transplant Diagnostics business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global Transplant Diagnostics Market.

Some of the prominent player active in global Transplant Diagnostics Market include Abbott Laboratories, Inc. Bio-Rad Laboratories, Inc. F. Hoffmann-LA Roche, Ltd. Illumina, Inc. Immucor, Inc. Linkage Biosciences,  Olerup SSp AB,  Qiagen N.V. , Sigma-Aldrich,  Thermo Fisher Scientific, Inc.

Segmentation:

By Technology:

• Molecular Assay Technologies
  • Sequencing-based Molecular Assays
  • PCR-Based Molecular Assays
• Non-molecular Assay Technologies

By Product & Service:

• Software & Services
• Instruments
• Reagents & Consumables

By Transplant Type:

• Bone marrow Transplantation
• Solid Organ Transplantation
• Soft Tissue Transplantation
• Stem Cell Transplantation

By Application:

• Diagnostic Applications
  • Pre-transplantation Diagnostics
  • Post-transplantation Diagnostics
• Research Applications

By End-User:

• Research Laboratories & Academic Institutes
• Hospitals & Transplant Centers
• Independent Reference Laboratories

By Geography

• North America
  • United States
  • Canada
  • Rest of North America
• Europe
  • Germany
  • United Kingdom
  • Belgium
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • India
  • China
  • Australia
  • Rest of Asia Pacific
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Rest of Middle East & Africa
• South America
  • Brazil
  • Rest of South America